SecBot SecBot
Home › SEC Filings › Current Report (8-K)

Current Report (8-K)

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
LASE8-Kneutral3/10Laser Photonics Corp appointed Tim Peterman as permanent CFO and Secretary, formalized via an employment agreement with Oct 20, 2026
ALLY8-Kbearish5/10Ally Financial reported Q3 2026 GAAP EPS of $1.30 (Adjusted EPS $1.34), a 10% YoY increase, on GAAP total net revenue ofOct 20, 2026
VICR8-Kbullish7/10Vicor reported Q3 2026 revenue of $197.1M (up 78.5% YoY) and diluted EPS of $1.33, beating consensus estimates of $1.23 Oct 20, 2026
HTZ8-Kneutral5/10Hertz Global Holdings has completed a sale of a ~15.86% stake in its autonomous vehicle subsidiary Oro Mobility HoldingsOct 20, 2026
CWEN8-Kneutral3/10Clearway Energy released an operational data preview for Q3 2026, reporting that wind and solar resource was in line witOct 20, 2026
VMI8-Kbullish6/10Valmont Industries reported Q3 2026 EPS of $6.24, a 13.8% beat vs consensus of $5.48, on revenue of $1.10B (in line withOct 20, 2026
FLUT8-Kbearish6/10Flutter Entertainment announced a restructuring of its UK & Ireland business, cutting up to 1,400 jobs (15.6% of its 9,0Oct 20, 2026
IRDM8-Kneutral5/10Iridium reported Q3 2026 total revenue of $245.7M (+8% YoY) and GAAP net income of $106.9M ($0.98/diluted share), which Oct 20, 2026
UCB8-Kmixed6/10United Community Banks reported Q3 2026 operating EPS of $0.77, a 6.7% miss vs consensus of $0.83, and operating revenueOct 20, 2026
INSM8-Kneutral3/10Insmed appointed Paul Hudson (former CEO of Sanofi and Novartis Pharmaceuticals) and Utpal Koppikar (CFO of Verily HealtOct 20, 2026
MBRX8-Kneutral4/10Moleculin Biotech filed an 8-K to announce a 1-for-20 reverse stock split, effective October 20, 2026, reducing outstandOct 20, 2026
ODTX8-Kbullish6/10Odyssey Therapeutics presented completed Phase 2a induction results for OD-001, a first-in-class oral RIPK2 scaffolding Oct 20, 2026
AIB8-Kneutral4/10AIB Data Centers Inc. released an October 2026 investor presentation via an 8-K (Item 7.01 Regulation FD Disclosure). ThOct 20, 2026
RTX8-Kbullish7/10RTX reported Q3 2026 results with strong double-digit sales and earnings growth, and raised its full-year 2026 guidance Oct 20, 2026
KR8-Kneutral5/10Kroger held an investor update introducing new long-term financial targets: approximately 3% comparable sales growth (exOct 20, 2026
HAL8-Kbearish6/10Halliburton reported Q3 2026 adjusted EPS of $0.60, a 6.3% sequential decline from Q2's $0.64, on flat revenue of $5.7B.Oct 20, 2026
AUB8-Kneutral4/10Atlantic Union Bankshares reported Q3 2026 GAAP diluted EPS of $0.94, slightly below the $0.98 consensus estimate, whileOct 20, 2026
MSCI8-Kneutral4/10MSCI reported Q3 2026 results with operating revenues of $892.0M (+12.4% YoY) and diluted GAAP EPS of $4.86 (+14.4% YoY)Oct 20, 2026
MMM8-Kbullish7/103M reported Q3 2026 adjusted EPS of $2.50, a 22.9% beat vs the $2.03 consensus, on adjusted sales of $6.6B (+4.2% YoY). Oct 20, 2026
QNRX8-Kbullish6/10Quoin Pharmaceuticals announced the publication of a peer-reviewed paper in Dermatology and Therapy detailing a pediatriOct 20, 2026
HAS8-Kbullish7/10Hasbro reported Q3 2026 adjusted EPS of $2.90, a 93.2% beat vs. the $1.50 consensus, on revenue of $1.595B (11.5% above Oct 20, 2026
EFX8-Kmixed6/10Equifax reported Q3 2026 revenue of $1.6925B (+10% YoY) and adjusted EPS of $2.26 (+11% YoY), beating consensus estimateOct 20, 2026
GE8-Kbullish7/10GE Aerospace reported Q3 2026 adjusted EPS of $2.25, a 36% YoY increase, on adjusted revenue of $13.3B (+18% YoY). The cOct 20, 2026
KEY8-Kbullish6/10KeyCorp reported Q3 2026 EPS of $0.51, a 1.9% beat vs consensus of $0.50, on record revenue of $2.04B (+8% YoY). Net intOct 20, 2026
BNAI8-Kneutral3/10Brand Engagement Network provided an update on cost reduction actions related to its June 30, 2026 acquisition of CataneOct 20, 2026
DCOM8-Kmixed6/10Dime Commercial Bancshares reported Q3 2026 GAAP diluted EPS of $0.90 (adjusted $0.91), a 53% YoY increase, on record quOct 20, 2026
PEBO8-Kneutral5/10Peoples Bancorp reported Q3 2026 GAAP diluted EPS of $0.91, a 9.6% YoY increase from $0.83, but a 2.3% miss vs the $0.93Oct 20, 2026
RAPP8-Kbullish7/10Rapport Therapeutics announced positive topline Phase 2 results for RAP-219 in acute bipolar mania, meeting the primary Oct 20, 2026
KMB8-Kneutral4/10Kimberly-Clark priced a $4.9 billion private offering of senior unsecured notes across five tranches to fund the cash coOct 20, 2026
SYF8-Kneutral3/10Synchrony Financial furnished its monthly charge-off and delinquency statistics for the thirteen months ended September Oct 20, 2026
« Previous Page 74 of 334 Next »